D.C. cannabis company rolls out new
health care brand with a pharma playbook.
Introduction
A Washington, D.C., medical marijuana
company is launching a new brand that will sell cannabis products specifically
targeting health care providers and researchers.
The new line of products, called Care by
Design, follows an approach that combines traditional pharmaceutical techniques
with marijuana science to help researchers understand the effects of medical
marijuana and its potential risks.
It's particularly useful for doctors who are
increasingly asked about marijuana by patients but lack the information needed
to respond well.
While some doctors may be reluctant to
recommend cannabis for their patients for various reasons, others believe it
has the strength to be a viable treatment option for people with cancer or
epilepsy, and multiple sclerosis are two examples of neurological disorders.
Care by Design is expected to launch its
first product next week, with others following in the coming weeks and months.
A Washington, D.C., medical
marijuana company
A Washington, D.C., medical marijuana
company is launching a new brand that will sell cannabis products specifically
targeting health care providers and researchers.
The new brand, Health for Life Research,
aims to provide "high-quality clinical research grade medical cannabis
products" to doctors and scientists researching the plant's medicinal
properties.
The target audience is not patients or
consumers but rather physicians and researchers looking into how cannabis can
be used as medicine in daily life.
A study published this week shows that
public support for legalizing marijuana has increased significantly over time,
especially among younger Americans who are more likely to use it recreationally
or medically than older generations.
The new line of products,
called Care by Design.
Care by Design is a line of health care
products that follows an approach that combines traditional pharmaceutical
techniques with marijuana science to help researchers understand the effects of
medical marijuana and its potential risks.
According to Dr. Raphael Machoulam,
co-founder of Care by Design and professor emeritus at Hebrew University in
Israel, the company uses a pharma playbook.
The company has grown a patented process for
extracting cannabinoids from cannabidiol (CBD), which he said can be used as an
ingredient in foods and beverages and other forms such as capsules or pills.
It also created a new form of CBD oil with
greater bioavailability than others currently on the market, meaning that your
body can absorb it better than other versions you might take orally.
It's particularly useful for
doctors.
The medical establishment has long viewed
the cannabis industry as a lawless wasteland of pot-addled hippies and lazy
stoners.
But in recent years, many doctors and
scientists have seen that marijuana can effectively treat pain, anxiety,
depression, and even cancer. Some are even advocating for its outright
legalization.
And yet, despite all this progress, major
obstacles still stand in the way of the widespread acceptance of cannabis as
medicine.
There is a lack of standard research on how
best to prescribe it for various conditions, a gap that Dixie is trying to fill
with its new brand of THC-infused beverages (which will also contain CBD).
The company's plan is to educate doctors
about how these products work and help patients use them safely by offering
advice about dosage amounts based on their tolerance levels for THC versus CBD.
This new brand intends to
help improve cannabis science
As a D.C.-based cannabis company, this is
where we have a lot of expertise. We've worked with doctors, nurses, and other
health care providers for years, and we understand how they think about
cannabis.
We want to help improve patients' quality of
care by bringing in scientific data on dosing, THC/CBD ratios, and other
information on best practices for pharmacists and physicians alike.
Conclusion
Ultimately, it's clear that cannabis has a
lot of potentials. It's already being used to treat some conditions and could
be useful for others in the future.
But research on this drug is still very
limited, and there are many unanswered questions about its effects and risks,
which keep researchers from recommending it as a medical treatment option for
patients.
To address these issues, companies like Care
by Design have stepped up their efforts to improve cannabis science by
providing products that help researchers better understand how marijuana works
in the body while also helping doctors better educate their patients about what
they might expect if they choose to try using this drug as an alternative
therapy option.